Dosage Forms

Articles

Medical researchers from the Centenary Institute and the University of Sydney in Australia have managed to successfully develop and test a new vaccine targeting tuberculosis.

Australian Researchers Successfully Develop New Tuberculosis Vaccine

ABPI has issued a statement of support in response to the United Kingdom’s Prime Minister’s recent order of urgent action to boost the numbers of children receiving vaccinations.


Industry Stresses Importance of Tackling Vaccine Hesitancy

The new facility will manufacture biopharmaceutical products under cGMP conditions.

HALIX Completes New cGMP Manufacturing Facility; Startup Slated for Q4 2019

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

As vaccines gain prominence within pharma, there is an expectation that specialized CDMO services will provide opportunities.

Realizing the Potential of Vaccines

The Native Antigen Company has revealed its appointment of Biozol and Shanghai Bioleaf as its distributors in Germany, Switzerland, Austria, and China

The Native Antigen Company Appoints Biozol and Shanghai Bioleaf as Distributors

The Wellcome Global Monitor has demonstrated an overall positive trust in science but some concerns still remain on attitudes on vaccines.


A Wellcome Result for Science

The Michelson Medical Research Foundation and the Human Vaccines Project have awarded three young scientists $150,000 for their novel approaches toward human immune system research.

2019 Michelson Prize Winners Announced

The agency updated its list of recommended influenza virus strains that manufacturers should include in vaccines for the autumn 2019 season.

EMA Updates Flu Vaccine Recommendations

WHP has been awarded with the design contract for the United Kingdom’s first dedicated vaccines manufacturing innovation center (VMIC).

WHP Wins Design Contract for UK’s First Dedicated Vaccines Manufacturing Innovation Center

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health (NIH), awarded grants totaling $41.6 million to establish four cooperative research centers focused on developing vaccines to prevent sexually transmitted infections (STIs).